IBT
ARVN icon

International Biotechnology Trust’s Arvinas ARVN Stock Holding History

International Biotechnology Trust’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$334K Hold
17,000
– – 0.11% 63
2023
Q2 		$421K Hold
17,000
– – 0.13% 59
2023
Q1 		$464K Hold
17,000
– – 0.13% 60
2022
Q4 		$581K Hold
17,000
– – 0.18% 58
2022
Q3 		$756K Buy
+17,000
New +$825K 0.24% 55

Other funds holding ARVN

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

International Biotechnology Trust's ARVN Position: Q3 2023 in Review

International Biotechnology Trust held its Arvinas (ARVN) position steady in Q3 2023 at 17,000 shares worth $334K. The position accounts for 0.11% of the portfolio, ranked #63.

International Biotechnology Trust first reported a position in ARVN in Q3 2022 and has held it in 5 quarters since. The position peaked at $756K in Q3 2022. 154 funds tracked by Wall St. Rank hold ARVN as of Q3 2023.

  • International Biotechnology Trust held 17,000 shares of Arvinas worth $334K as of Q3 2023.
  • International Biotechnology Trust left its Arvinas share count unchanged in Q3 2023.
  • Arvinas made up 0.11% of International Biotechnology Trust's portfolio in Q3 2023, its #63 holding.
  • International Biotechnology Trust first reported a position in Arvinas in Q3 2022 and has held it in 5 quarters since.
  • International Biotechnology Trust's Arvinas position peaked at $756K in Q3 2022.
  • 154 funds tracked by Wall St. Rank held Arvinas as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.